Valuation: Yuhan Corporation

Market Cap 5,964B 4.5B 4.03B 3.73B 3.38B 6.31B 427B 6.39B 44.66B 17.74B 224B 16.87B 16.51B 710B P/E 2026 *
40.9x
P/E 2027 * 29.4x
Enterprise Value 5.94B 4.48M 4.02M 3.71M 3.37M 6.29M 425M 6.37M 44.51M 17.68M 223M 16.82M 16.46M 707M EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.31x
Free-Float
59.15%
Yield 2026 *
0.75%
Yield 2027 * 0.72%
1 day-2.08%
1 week-7.19%
Current month+9.89%
1 month+7.96%
3 months+11.11%
6 months-14.98%
Current year-28.83%
1 week 79,700
Extreme 79700
86,500
1 month 69,000
Extreme 69000
89,800
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 53,809.52
Extreme 53809.523809
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 18/03/2021
Director of Finance/CFO 58 -
President 67 14/03/2024
Director TitleAgeSince
Chairman 74 18/03/2021
Director/Board Member 71 19/03/2015
Director/Board Member 62 29/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-7.19%-33.05%+47.89% 4.59B
+0.22%-0.14%+55.12%+128.82% 1,140B
+0.91%+3.61%+41.21%+84.57% 641B
-0.12%-0.93%+25.59%+106.14% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.86%-4.37%+61.16%+37.93% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.75%+2.05%+53.85%+71.25% 240B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.22%+0.28%+31.22%+73.24% 401.84B
Weighted average by Cap. +0.44%+0.95%+42.12%+88.43%

Financials

2026 *2027 *
Net sales 2,348B 1.77B 1.59B 1.47B 1.33B 2.49B 168B 2.52B 17.58B 6.98B 88.11B 6.64B 6.5B 279B 2,549B 1.92B 1.72B 1.59B 1.44B 2.7B 183B 2.73B 19.09B 7.58B 95.66B 7.21B 7.06B 303B
Net income 150B 113M 101M 93.65M 84.93M 159M 10.73B 161M 1.12B 446M 5.63B 424M 415M 17.84B 201B 152M 136M 126M 114M 213M 14.4B 215M 1.51B 598M 7.55B 569M 557M 23.93B
Net Debt -20.82B -15.7M -14.09M -13.01M -11.8M -22.05M -1.49B -22.32M -156M -61.93M -781M -58.92M -57.66M -2.48B -83.34B -62.82M -56.38M -52.06M -47.21M -88.23M -5.97B -89.32M -624M -248M -3.13B -236M -231M -9.92B
Projected Income Statement - Annual - Yuhan Corporation
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
27/10/26 ₩80,000.00 -2.08% 196,144
26/10/26 ₩81,700.00 -3.54% 165,207
23/10/26 ₩84,700.00 +0.83% 386,541
22/10/26 ₩84,000.00 -3.00% 340,784
21/10/26 ₩86,600.00 +0.46% 405,730
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Yuhan Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
80,000.00KRW
Average target price
112,058.82KRW
Spread / Average Target
+40.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yuhan Corporation
  1. Stock Market
  2. Stocks
  3. A000100 Stock